Search Results - "Handjiev, Sava"

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis by Gurun, Marc, Brennan, Paul, Handjiev, Sava, Khatib, Aseil, Leith, Damien, Dillon, John F, Byrne, Christopher J

“…Metabolic dysfunction associated steatotic liver disease (MASLD) increases the risk of incident chronic kidney disease (CKD). However, the relative risk of CKD…”
Get full text

Intelligent Liver Function Testing (iLFT): An Intelligent Laboratory Approach to Identifying Chronic Liver Disease by Nobes, Jennifer, Leith, Damien, Handjiev, Sava, Dillon, John F, Dow, Ellie

“…The intelligent Liver Function Testing (iLFT) pathway is a novel, algorithm-based system which provides automated laboratory investigations and clinical…”
Get full text

OS-007-YI Intelligent liver function test 5 years on-the evolution of an intelligent platform by Leith, Damien, Nobes, Jennifer, Handjiev, Sava, Macpherson, Iain, Dow, Ellie, Dillon, John F

Get full text

Efficacy and tolerability of PCSK9 inhibitors in real-world clinical practice by Devaiah, Prashasthi, Handjiev, Sava, George, Jacob

“…Despite widespread use of statins and other lipid-lowering therapies for hypercholesterolaemia, cardiovascular (CV) mortality and morbidity remains high. The…”
Get full text

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis by Marc Gurun, Paul Brennan, Sava Handjiev, Aseil Khatib, Damien Leith, John F Dillon, Christopher J Byrne

“…Background and aimsMetabolic dysfunction associated steatotic liver disease (MASLD) increases the risk of incident chronic kidney disease (CKD). However, the…”
Get full text